On-Demand Webinar: Hepatitis B Prevention and Management: What Happens When the Guidelines Fail Us

On-Demand Webinar: Hepatitis B Prevention and Management: What Happens When the Guidelines Fail Us

Presenter: Kenneth E. Sherman, MD, PhD

Release date: June 15, 2021
Expiration date: June 15, 2022
CME Credit Available: 1.25 AMA PRA Category 1 Credits

Overview

Assessment of Needs

This state-of-the-art activity is part of a nationwide continuing education effort for physicians on the evolving challenges of managing relevant viral infections and concomitant diseases and comorbidities. Hepatitis B virus (HBV) infection remains a global health concern. In this webinar, we will review the epidemiology of HBV infection and the ways that we can prevent infection with a focus on immunosuppressed populations. We will then review treatment of HBV infection, including patient selection, medication use, and monitoring of those with chronic disease. Finally, we will focus on the role occult HBV infection plays in disease reactivation and the risk of hepatocellular carcinoma.

Learning Objectives

On completion of this webinar, learners will be able to:

  • Describe current principles of hepatitis B prevention and the risk of vaccine failure in immunosuppressed populations
  • Determine when to treat hepatitis B and when or if such treatment should be discontinued
  • Describe the risks associated with occult hepatitis B and when monitoring and treatment might be indicated

Registration

Who Should Attend

This webinar is designed for clinical decision makers who are actively involved in managing relevant viral infections and concomitant diseases and comorbidities.

This activity is also relevant for nursing professionals, physician assistants, pharmacists, and other health care professionals.

Please note: if you already have participated on the live webinar and have received CME credits, you will not receive additional credits from this activity.

Conflicts of Interest

Dr Sherman has received grant support or contracts awarded to his institution from AbbVie, Gilead Sciences, Inc, Intercept Pharmaceuticals, Inc, MedImmune, and Merck & Co, Inc; served as an advisor or consultant to UniQure and Inovio Pharmaceuticals; and served on data and safety monitoring boards for Watermark and Medpace. (Updated 04/13/21)

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Presenter Disclosure

Dr Sherman has received grant support or contracts awarded to his institution from AbbVie, Gilead Sciences, Inc, Intercept Pharmaceuticals, Inc, MedImmune, and Merck & Co, Inc; served as an advisor or consultant to UniQure and Inovio Pharmaceuticals; and served on data and safety monitoring boards for Watermark and Medpace. (Updated 04/13/21)

All relevant financial relationships have been mitigated.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points

ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

PLATINUM SUPPORTERS

Gilead Sciences, Inc.
Merck & Co., Inc.
ViiV Healthcare

SILVER SUPPORTER

Janssen Therapeutics

BRONZE SUPPORTER

Theratechnologies Inc.

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration@iasusa.org or 415-544-9400.

Course Materials

How to Claim Credit

  1. Start the Activity by clicking "START COURSE" located above.
    Please note that the "START COURSE" will no longer be visible once you clicked it once.
  2. Watch the webinar here.
  3. Return to this page and follow this link to the evaluation form.
  4. Once you complete the evaluation, you will be directed to the online claim form, where you will record the number of hours that you participated in this activity. You must be logged in to your IAS–USA profile to claim credit. Please note: if you already have participated on the live webinar and have received CME credits, you will not receive additional credits from this activity.
  5. Your certificate will be available for you to print from your IAS–USA account immediately after you have submitted your claim form. To view your certificates, go to "My Activities" under your profile.